95 related articles for article (PubMed ID: 3313883)
1. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
[No Abstract] [Full Text] [Related]
2. Therapeutic effect of antiplatelet agents on obstructive vascular lesions after kidney transplantation with cyclosporine.
Teraoka S; Oba S; Takahashi K; Yagisawa T; Yamaguchi Y; Sanaka T; Tanabe K; Kawai T; Fuchinoue S; Honda H
Transplant Proc; 1987 Aug; 19(4 Suppl 5):77-81. PubMed ID: 3303573
[No Abstract] [Full Text] [Related]
3. Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor.
Teraoka S; Takahashi K; Toma H; Ota K
Transplant Proc; 1993 Apr; 25(2):2085-6. PubMed ID: 8470279
[No Abstract] [Full Text] [Related]
4. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
Moriuchi M
Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
[No Abstract] [Full Text] [Related]
5. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
[No Abstract] [Full Text] [Related]
6. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
[No Abstract] [Full Text] [Related]
7. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor].
Katoh K; Kani H; Imai T
Masui; 1985 Jul; 34(7):966-72. PubMed ID: 4057547
[No Abstract] [Full Text] [Related]
8. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
Sakio H; Usui Y; Mita H; Onoda N; Iida M; Okuda C
Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
[No Abstract] [Full Text] [Related]
9. Selective thromboxane synthetase inhibitor and ischemic heart disease.
Ito T; Ogawa K; Watanabe J; Chen LS; Shikano M; Imaizumi M; Shibata T; Ito Y; Miyazaki Y; Satake T
Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
[No Abstract] [Full Text] [Related]
10. New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation.
Teraoka S; Takahashi K; Toma H; Yagisawa T; Yamaguchi Y; Sanaka T; Fuchinoue S; Honda H; Kawai T; Tanabe K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2115-9. PubMed ID: 3547915
[No Abstract] [Full Text] [Related]
11. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
Ohsugi S
Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
[No Abstract] [Full Text] [Related]
12. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
Okamoto S; Yonekawa Y; Handa H; Handa Y; Uemura Y; Yano I; Toyoshima M; Iwatsuji K; Teraura T; Yamagata S
Nihon Geka Hokan; 1986 Jan; 55(1):251-9. PubMed ID: 3741043
[No Abstract] [Full Text] [Related]
13. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
Suzuki S; Akama H; Kume K; Higuchi E; Kamiyama S; Suzuki J; Ohara N; Yugeta E; Kato K; Suzuki H
Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):341-6. PubMed ID: 3230687
[No Abstract] [Full Text] [Related]
14. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
Chan RC; Durity FA; Thompson GB; Nugent RA; Kendall M
J Neurosurg; 1984 Dec; 61(6):1120-8. PubMed ID: 6389786
[TBL] [Abstract][Full Text] [Related]
15. [The effects of thromboxane A2 synthetase inhibitor on chronic rejection of kidney transplantation].
Imanishi M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):895-901. PubMed ID: 2402113
[TBL] [Abstract][Full Text] [Related]
16. [A double-blind placebo-controlled study of OKY-046 in the treatment of chronic asthma].
Kabe J
Nihon Naika Gakkai Zasshi; 1989 Sep; 78(9):1288-92. PubMed ID: 2687415
[No Abstract] [Full Text] [Related]
17. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
[No Abstract] [Full Text] [Related]
18. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
Yonekawa Y; Handa H; Okamoto S; Ohta T; Kamijo Y; Oda Y; Kondo A; Nin K; Yamamoto T; Ban S
Nihon Geka Hokan; 1986 May; 55(3):473-84. PubMed ID: 3541826
[No Abstract] [Full Text] [Related]
19. Effect of prostaglandin I2 analogue and thromboxane A2 synthetase inhibitor on chronic rejection in rats.
Hirano T; Nakafusa Y; Nishinaka H; Takeda K; Kawano R; Nakano M; Arima T; Motoyama K; Nakamura K; Torada N; Ikematsu H; Kamei T; Tanaka M
Transplant Proc; 1997; 29(1-2):1520. PubMed ID: 9123408
[No Abstract] [Full Text] [Related]
20. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
